Hypermethylated promoter profiles were related to IDH mutation, yet not randomly in IDH-mutated gliomas, because LATS2 promoter hypermethylation was more frequent in oligodendroglioma than in astrocytoma. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).